These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16645328)

  • 1. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR; Calabro A
    Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
    Konecny G; Untch M; Slamon D; Beryt M; Kahlert S; Felber M; Langer E; Lude S; Hepp H; Pegram M
    Breast Cancer Res Treat; 2001 Jun; 67(3):223-33. PubMed ID: 11561768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: preliminary results of an in vitro study.
    Ozturk OH; Bozcuk H; Burgucu D; Ekinci D; Ozdogan M; Akca S; Yildiz M
    Cell Biol Int; 2007 Sep; 31(9):1069-71. PubMed ID: 17418595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system.
    Budman DR; Calabro A; Rosen L; Lesser M
    Anticancer Drugs; 2012 Mar; 23(3):272-9. PubMed ID: 23427335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
    Pegram MD; Konecny GE; O'Callaghan C; Beryt M; Pietras R; Slamon DJ
    J Natl Cancer Inst; 2004 May; 96(10):739-49. PubMed ID: 15150302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
    Budman DR; Tai J; Calabro A
    Breast Cancer Res Treat; 2007 Jul; 104(1):93-101. PubMed ID: 17004104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid.
    Ullén A; Lennartsson L; Harmenberg U; Hjelm-Eriksson M; Kälkner KM; Lennernäs B; Nilsson S
    Acta Oncol; 2005; 44(6):644-50. PubMed ID: 16165924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
    Knight LA; Kurbacher CM; Glaysher S; Fernando A; Reichelt R; Dexel S; Reinhold U; Cree IA
    BMC Cancer; 2009 Jan; 9():38. PubMed ID: 19175937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
    Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC
    Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women.
    Thompson K; Keech F; McLernon DJ; Vinod K; May RJ; Simpson WG; Rogers MJ; Reid DM
    Bone; 2011 Jul; 49(1):140-5. PubMed ID: 21047568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
    Szafran AA; Folks K; Warram J; Chanda D; Wang D; Zinn KR
    Cancer Biol Ther; 2009 Jun; 8(12):1109-16. PubMed ID: 19652526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
    Knight LA; Conroy M; Fernando A; Polak M; Kurbacher CM; Cree IA
    Anticancer Drugs; 2005 Oct; 16(9):969-76. PubMed ID: 16162973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine in combination with trastuzumab and/or platinum salts in breast cancer cells with HER2 overexpression.
    Konecny GE; Pegram MD
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):32-6. PubMed ID: 15685824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells.
    Kars MD; Işeri OD; Ural AU; Gündüz U
    Anticancer Res; 2007; 27(6B):4031-7. PubMed ID: 18225567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.
    Bocci G; Fioravanti A; Orlandi P; Bernardini N; Collecchi P; Del Tacca M; Danesi R
    Br J Cancer; 2005 Aug; 93(3):319-30. PubMed ID: 16052215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
    Jagdev SP; Coleman RE; Shipman CM; Rostami-H A; Croucher PI
    Br J Cancer; 2001 Apr; 84(8):1126-34. PubMed ID: 11308265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83.
    Ge XY; Yang LQ; Jiang Y; Yang WW; Fu J; Li SL
    PLoS One; 2014; 9(6):e101207. PubMed ID: 24963720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
    Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
    Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro.
    Budman DR; Calabro A; Kreis W
    Anticancer Drugs; 2002 Nov; 13(10):1011-6. PubMed ID: 12439335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
    Koto K; Murata H; Kimura S; Horie N; Matsui T; Nishigaki Y; Ryu K; Sakabe T; Itoi M; Ashihara E; Maekawa T; Fushiki S; Kubo T
    Oncol Rep; 2010 Jul; 24(1):233-9. PubMed ID: 20514467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.